Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease-Reference-Cited by-同舟云学术

Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease

Published:2020 Issue:66 Volume:10 Page:40244-40263
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Frecer Vladimir¹²³⁴⁵^ORCID,Miertus Stanislav⁶⁴⁵⁷⁸

Affiliation:

1. Department of Physical Chemistry of Drugs

2. Faculty of Pharmacy

3. Comenius University in Bratislava

4. Bratislava

5. Slovakia

6. International Centre for Applied Research and Sustainable Technology (ICARST)

7. Department of Biotechnology

8. Faculty of Natural Sciences

Abstract

Structure-based design of SARS-CoV-2 main protease inhibitors identified hydantoin, benzothiazine and cresol moieties as promising residues of new peptidomimetic inhibitors.

Funder

Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Agentúra na Podporu Výskumu a Vývoja

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/D0RA08304F

Reference56 articles.

1. A new coronavirus associated with human respiratory disease in China

2. A pneumonia outbreak associated with a new coronavirus of probable bat origin

3. Current pharmacological treatments for COVID‐19: What's next?

4. Emerging coronaviruses: Genome structure, replication, and pathogenesis

5. Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Estimation of Residues Involving Resistance to the SARS-CoV-2 Main Protease Inhibitor Ensitrelvir Based on Virtual Alanine Scan of the Active Site;Biological and Pharmaceutical Bulletin;2024-05-17

2. A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds;Drug Design, Development and Therapy;2024-05

3. Design and synthesis of novel main protease inhibitors of COVID-19: quinoxalino[2,1-b]quinazolin-12-ones;RSC Advances;2024

4. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series;Current Computer-Aided Drug Design;2023-08-23

5. Targeting SARS-CoV-2 Non-Structural Proteins;International Journal of Molecular Sciences;2023-08-20